Press release
Numerous Untapped Opportunities in Clinical Development Exist in the Pancreatic Cancer Market
Pancreatic cancer is a key challenge in the United States, where the 30,000 patients are diagnosed with the disease each year. The U.S. has the highest number of pancreatic cancer patients in the world. With less than five-year survival, the pancreatic cancer market has among the highest unmet therapy needs in the overall oncology market.
Download Exclusive Sample of this Report: http://bit.ly/2eoACRZ
Evidently, this is also the greatest challenge that the pancreatic cancer market needs to address. Given the aggressive nature of pancreatic cancer, treatments often return inadequate results. This aspect is yet another barrier to the growth of this market.
Technologies for the timely diagnosis of this cancer type are yet to develop fully, which results in a majority of pancreatic cancer patients being diagnosed at an advanced stage of the disease. This reflects in the high mortality rates associated with pancreatic cancer. Estimates show that only a small percentage (about 12% to 15%) of patients is diagnosed early enough to be treated with surgical procedures, drugs, and chemotherapy. Pancreatic cancer begins at stage I, with the subsequent stages being: stage II, stage III, and stage IV. Only stage I and stage II pancreatic cancers can be surgically removed.
The pancreatic cancer market is segmented based on whether the cancer affects endocrine or exocrine functions. Adenocarcinomas, which constitutes nearly 95% of all exocrine pancreatic cancers, is the most common pancreatic cancer type. Other prevalent cancers of the pancreas that affect endocrine functions include: squamous cell carcinomas, adenosquamous carcinomas, and giant cell carcinomas.
The pancreatic cancer drug market is dominated by Gemzar (Gemcitabine) developed by Eli Lilly. Gemzar is ranks among the most advanced types of drug therapies recommended advanced stage treatments (stage III and stage IV). A majority of the pancreatic cancer drug market is led by Gemzar developed by Eli Lilly and Tarceva(Erlotinib), by Genentech/ OSI Pharmaceuticals/ Roche as they have been in the market for a considerable time.
Browse Research Report: http://bit.ly/2enltiI
Abraxane by Celgene, is another therapeutic drug that was launched in the US in 2013, and in Europe in 2014. Abraxane was the first drug to be approved for pancreatic cancer treatment in almost a decade, and is expected to aggressively compete with existing drugs. A few pipeline drugs are expected to be launched toward the end of the forecast period. Numerous untapped opportunities in clinical development exist in the pancreatic cancer market.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Numerous Untapped Opportunities in Clinical Development Exist in the Pancreatic Cancer Market here
News-ID: 374791 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Numerous
Detention facilities face numerous and long-standing issues
Detention facilities face numerous and long-standing issues that have drawn significant criticism from human rights organizations, advocates, and government watchdogs. These issues have garnered serious concerns about the humane conditions, as well as the overall effectiveness and quality of the current detention system at both public and private facilities nationwide.
Today's world needs safe, anti-ligature, humanized facilities for incarceration and detention, both temporary and long-term. Ranging from family-friendly to hardened…
Mushroom Market Driven by their Numerous Advantages
Global Mushroom Market: Overview
The sales of mushrooms and mushroom-based products are high across retail outlets and thus, the robust growth of the retail sector worldwide is working in favor of the global mushrooms market. There are various types of mushrooms available in the market, including button mushroom, oyster mushroom, and shiitake mushroom. They are primarily available in fresh or processed form. The processed form is further divided into canned,…
Microwaveable Foods Market Driven by their Numerous Advantages
Despite being a multibillion-dollar industry, the rising awareness among consumers about the dangers associated with microwaving foods packed in plastic wraps or containers is anticipated to suppress the microwaveable foods market’s growth to an extent. Certain plasticizers such as BPA and phthalates are endocrine disrupters, which have an adverse impact on the human health since they mimic human hormones. To ensure safety of the population, the U.S. FDA closely monitors…
Nutraceuticals Market Driven by their Numerous Advantages
Global Nutraceuticals Market: Snapshot
The increasing consumer spending on functional food and beverages has been presenting lucrative prospects for the global nutraceuticals market. Consumers, especially those across developed nations, are currently exploring healthier lifestyle choices to curb the incidence of chronic and lifestyle diseases. Such trends have bolstered demand for dietary supplement not only as means to boost physical performance but also disease prevention option. Spurred by such factors, Transparency…
Sweet Potatoes Market Driven by their Numerous Advantages
Sweet potatoes are basically root vegetable which is rich in starch, vitamins, potassium, fiber and higher source of beta carotene. They primarily considered as a staple food as have significant proportion in form of daily routine intake food products. Nowadays the product has become more popular due to its wide application in ethnic cuisines, culinary uses, everyday meal and many other food products. This has insist the food manufacturers and…
ISO Recruiting Consultants acquires numerous new customers
After a successful 2015, the ISO Recruiting Consultants GmbH is already flying high in 2016, with numerous new customers in the first quarter.
ISO Recruiting Consultants (IRC) continues its successful course in the market for personnel services in the IT domain. Here are some examples of new projects from the first quarter that demonstrate the scope of IT personnel services the IRC offers and the range of industries it serves.
For a…
